BF

Barry Falgout

US US Dept of Health & Human Services: 2 patents #591 of 3,044Top 20%
📍 Rockville, MD: #335 of 2,038 inventorsTop 20%
🗺 Maryland: #4,710 of 35,612 inventorsTop 15%
Overall (All Time): #705,841 of 4,157,543Top 20%
7
Patents All Time

Issued Patents All Time

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
11753627 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 Stephen S. Whitehead, Brian R. Murphy, Lewis Markoff, Joseph E. Blaney, Kathryn A. Hanley +1 more 2023-09-12
10837003 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-utr of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4 Stephen S. Whitehead, Brian R. Murphy, Lewis Markoff, Joseph E. Blaney, Kathryn A. Hanley +1 more 2020-11-17
RE46641 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 Stephen S. Whitehead, Brian R. Murphy, Lewis Markoff, Joseph E. Blaney, Kathryn A. Hanley +1 more 2017-12-19
RE46631 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 Stephen S. Whitehead, Brian R. Murphy, Lewis Markoff, Joseph E. Blaney, Kathryn A. Hanley +1 more 2017-12-12
9783787 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4 Stephen S. Whitehead, Brian R. Murphy, Lewis Markoff, Joseph E. Blaney, Kathryn A. Hanley +1 more 2017-10-10
8075903 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4 Stephen S. Whitehead, Brian R. Murphy, Lewis Markoff, Joseph E. Blaney, Kathryn A. Hanley 2011-12-13
7517531 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 Stephen S. Whitehead, Brian R. Murphy, Lewis Markoff, Joseph E. Blaney, Kathryn A. Hanley 2009-04-14